Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancers make their own luck: theories of cancer origins
Amir Jassim, Eric P. Rahrmann, Benjamin D. Simons, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 710-724
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 85
Aging and cancer
Léa Montégut, Carlos López‐Otín, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 47
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Optimizing Cancer Treatment: Exploring the Role of AI in Radioimmunotherapy
Hossein Azadinejad, Mohammad Farhadi Rad, Ahmad Shariftabrizi, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 397-397
Open Access | Times Cited: 2
Exercise-induced extracellular vesicles in reprogramming energy metabolism in cancer
Marju Puurand, Alicia Llorente, Aija Linē, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
Qihui Wu, Xiaodan Fu, Guoqian Liu, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Very small embryonic-like stem cells (VSELs) on the way for potential applications in regenerative medicine
Kannathasan Thetchinamoorthy, Justyna Jarczak, Patrycja Kieszek, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1
Research progress of injectable hydrogels in the treatment of bone tissue diseases
Shengjie Zhang, Xiaohua Li, Chunxiao Li, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155139-155139
Closed Access | Times Cited: 8
An improved epigenetic counter to track mitotic age in normal and precancerous tissues
Tianyu Zhu, Huige Tong, Zhaozhen Du, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Deciphering the significance of p53 mutant proteins
Alessio Butera, Ivano Amelio
Trends in Cell Biology (2024)
Open Access | Times Cited: 6
Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy
Ziheng Luo, Cheng Xiang, Bin Feng, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 6
A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma
Linhua Liu, Bing Wang, Yibo Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Emerging strategies to investigate the biology of early cancer
Ran Zhou, Xiwen Tang, Yuan Wang
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 850-866
Closed Access | Times Cited: 5
Enhancing localized chemotherapy with anti-angiogenesis and nanomedicine synergy for improved tumor penetration in well-vascularized tumors
Mohammad Souri, Sohail Elahi, Farshad Moradi Kashkooli, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Imperfect wound healing sets the stage for chronic diseases
Paul Martin, Carlos Pardo-Pastor, Gisli Jenkins, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 5
Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 5
Potent prophylactic cancer vaccines harnessing surface antigens shared by tumour cells and induced pluripotent stem cells
Nan Li, Hao Qin, Fei Zhu, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 5
Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases
Alma Fuentes-Aguilar, Aday González‐Bakker, Mirna Jovanović, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107168-107168
Open Access | Times Cited: 4
Anticancer drugs: where are we now?
Giuseppina De Simone, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 7, pp. 525-527
Open Access | Times Cited: 4
Ethical Considerations and Implications of Multi-Cancer Early Detection Screening: Reliability, Access and Cost to Test and Treat
Lorenzo F. Sempere
Cambridge Quarterly of Healthcare Ethics (2025), pp. 1-10
Closed Access
Platelet indicators do not influence the impact of ABO blood groups on lung adenocarcinoma susceptibility
Ting Zhang, Mingfei Xiang, Hailin Yin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
Super-resolution microscopy as drug discovery tool
Lauren Toms, Louis J Fitzpatrick, Philip Auckland
SLAS DISCOVERY (2025) Vol. 31, pp. 100209-100209
Open Access
Single-cell DNA sequencing reveals pervasive positive selection throughout preleukemic evolution
Gladys Y. P. Poon, Aditi Vedi, Mathijs A. Sanders, et al.
Cell Genomics (2025), pp. 100744-100744
Open Access
Computed Tomography‐Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non‐Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy
Yuxin Geng, Tianwen Yin, Yikun Li, et al.
Molecular Carcinogenesis (2025)
Open Access
Page 1 - Next Page

Scroll to top